Details van artikel 337 van 426 gevonden artikelen
372 Safety and activity of the anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer
Titel:
372 Safety and activity of the anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer
Auteur:
Santin, A. Vergote, I. Martín, A. Moore, K. Oaknin, A. Romero, I. Diab, S. Copeland, L.J. Monk, B. Coleman, R. Herzog, T.J. Siegel, J. Walter, A. Childs, B.H. Elbi, C. Bulat, I.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A154
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 337 van 426 gevonden artikelen